Humana Inc. $HUM Shares Bought by Atria Wealth Solutions Inc.

Atria Wealth Solutions Inc. lifted its stake in Humana Inc. (NYSE:HUM) by 10.3% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 955 shares of the insurance provider’s stock after acquiring an additional 89 shares during the period. Atria Wealth Solutions Inc.’s holdings in Humana were worth $234,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently made changes to their positions in the stock. Janney Montgomery Scott LLC acquired a new stake in Humana during the first quarter valued at approximately $1,309,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in Humana by 16.2% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,136,538 shares of the insurance provider’s stock valued at $300,728,000 after purchasing an additional 158,528 shares during the last quarter. Focus Partners Wealth lifted its stake in Humana by 104.2% during the first quarter. Focus Partners Wealth now owns 6,429 shares of the insurance provider’s stock valued at $1,701,000 after purchasing an additional 3,281 shares during the last quarter. Envestnet Asset Management Inc. lifted its stake in Humana by 2.4% during the first quarter. Envestnet Asset Management Inc. now owns 125,684 shares of the insurance provider’s stock valued at $33,256,000 after purchasing an additional 2,950 shares during the last quarter. Finally, Circle Wealth Management LLC acquired a new stake in Humana during the first quarter valued at approximately $425,000. 92.38% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several analysts recently commented on HUM shares. Mizuho increased their target price on shares of Humana from $300.00 to $345.00 and gave the company an “outperform” rating in a research note on Thursday, October 9th. Truist Financial set a $300.00 price target on shares of Humana in a research report on Tuesday, October 14th. Weiss Ratings restated a “sell (d+)” rating on shares of Humana in a research report on Wednesday, October 8th. Barclays reduced their price target on shares of Humana from $315.00 to $245.00 and set an “equal weight” rating for the company in a research report on Friday, October 3rd. Finally, Robert W. Baird reduced their price target on shares of Humana from $300.00 to $297.00 and set a “neutral” rating for the company in a research report on Friday, July 25th. Eight analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $297.58.

Humana Stock Performance

Shares of HUM opened at $287.97 on Thursday. The company’s fifty day moving average is $281.38 and its 200-day moving average is $258.81. Humana Inc. has a 12 month low of $206.87 and a 12 month high of $315.35. The firm has a market cap of $34.63 billion, a price-to-earnings ratio of 22.10, a price-to-earnings-growth ratio of 1.73 and a beta of 0.42. The company has a quick ratio of 1.95, a current ratio of 1.95 and a debt-to-equity ratio of 0.69.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share (EPS) for the quarter, missing the consensus estimate of $6.32 by ($0.05). The firm had revenue of $32.39 billion for the quarter, compared to the consensus estimate of $31.85 billion. Humana had a return on equity of 13.67% and a net margin of 1.28%.Humana’s quarterly revenue was up 9.6% on a year-over-year basis. During the same period in the prior year, the company posted $6.96 earnings per share. Humana has set its FY 2025 guidance at 17.000- EPS. Equities analysts expect that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be issued a $0.885 dividend. The ex-dividend date of this dividend is Friday, September 26th. This represents a $3.54 dividend on an annualized basis and a yield of 1.2%. Humana’s dividend payout ratio is 27.17%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.